Enclosed herewith Unaudited Financial Results along with Limited Review Report issued by Statuory Auditor of the company for the Quarter ended June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evexia Lifecare filed its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26), along with a clean limited review report from statutory auditor M. A. Shah & Co. Standalone revenue from operations stood at Rs. 2,065.80 lakhs, marginally higher than Rs. 2,041.87 lakhs in Q1 FY25. Standalone net profit more than doubled to Rs. 58.69 lakhs from Rs. 26.43 lakhs a year ago, reversing the Rs. 49.04 lakh loss reported in the preceding quarter (Q4 FY25). On a consolidated basis, revenue was Rs. 2,209.32 lakhs (vs Rs. 2,122.77 lakhs YoY) and net profit jumped to Rs. 63.48 lakhs from Rs. 24.11 lakhs, a rise of about 163%. Standalone EPS was Rs. 0.003 and consolidated EPS was Rs. 0.03. The auditor issued an unqualified limited review conclusion with no qualifications, emphasis of matter, or going concern flag.
A sharp rebound in profitability and return to black after a loss-making Q4 FY25 is a positive signal for shareholders, though revenue growth remains modest and the absolute profit base is small. The clean auditor opinion removes any immediate governance red flags from this filing.